R. Fox, Sjögren's syndrome. Lancet, pp.23-29, 2005.

X. Mariette and J. Gottenberg, Pathogenesis of Sj??gren??s syndrome and therapeutic consequences, Current Opinion in Rheumatology, vol.22, issue.5, pp.471-478, 2010.
DOI : 10.1097/BOR.0b013e32833c36c5

E. Theander, G. Henriksson, O. Ljungberg, T. Mandl, and R. Manthorpe, Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors, Annals of the Rheumatic Diseases, vol.65, issue.6, pp.796-803, 2006.
DOI : 10.1136/ard.2005.041186

J. Ioannidis, V. Vassiliou, and H. Moutsopoulos, Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.39, issue.series B, pp.741-748, 2002.
DOI : 10.1002/art.10221

S. Kassan, T. Thomas, H. Moutsopoulos, R. Hoover, and R. Kimberly, Increased Risk of Lymphoma in Sicca Syndrome, Annals of Internal Medicine, vol.89, issue.6, pp.888-92, 1978.
DOI : 10.7326/0003-4819-89-6-888

R. Seror, P. Ravaud, S. Bowman, G. Baron, and A. Tzioufas, EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.1103-1112, 2010.
DOI : 10.1136/ard.2009.110619

F. Mackay, J. Groom, and S. Tangye, An important role for B-cell activation factor and B cells in the pathogenesis of Sj??gren??s syndrome, Current Opinion in Rheumatology, vol.19, issue.5, pp.406-419, 2007.
DOI : 10.1097/BOR.0b013e328277ef4c

M. Jonsson, P. Szodoray, S. Jellestad, R. Jonsson, and K. Skarstein, Association Between Circulating Levels of the Novel TNF Family Members APRIL and BAFF and Lymphoid Organization in Primary Sj??gren???s Syndrome, Journal of Clinical Immunology, vol.59, issue.3, pp.189-201, 2005.
DOI : 10.1007/s10875-005-4091-5

X. Mariette, S. Roux, J. Zhang, D. Bengoufa, and F. Lavie, The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.62, issue.2, pp.168-71, 2003.
DOI : 10.1136/ard.62.2.168

F. Lavie, C. Miceli-richard, M. Ittah, J. Sellam, and J. Gottenberg, B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sj??gren???s Syndrome, Scandinavian Journal of Immunology, vol.201, issue.2, pp.185-92, 2008.
DOI : 10.1111/j.1365-3083.2007.02049.x

C. Daridon, V. Devauchelle, P. Hutin, L. Berre, R. Martins-carvalho et al., BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome, Arthritis Rheum, vol.56, pp.1464-77, 2007.

J. Sellam, C. Miceli-richard, J. Gottenberg, M. Ittah, and F. Lavie, Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjogren's syndrome and systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.66, issue.6, pp.790-797, 2007.
DOI : 10.1136/ard.2006.065656

A. Novak, D. Grote, M. Stenson, S. Ziesmer, and T. Witzig, Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome, Blood, vol.104, issue.8, pp.2247-53, 2004.
DOI : 10.1182/blood-2004-02-0762

J. Gottenberg, M. Busson, J. Cohen-solal, F. Lavie, and K. Abbed, Correlation of serum B lymphocyte stimulator and ??2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.64, issue.7, p.1050, 2005.
DOI : 10.1136/ard.2004.030643

J. Gottenberg, F. Aucouturier, J. Goetz, C. Sordet, and I. Jahn, Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.66, issue.1, pp.23-30, 2007.
DOI : 10.1136/ard.2006.052159

J. Michalski, T. Daniels, N. Talal, and H. Grey, Microglobulin and Lymphocytic Infiltration in Sj??gren's Syndrome, New England Journal of Medicine, vol.293, issue.24, pp.1228-1259, 1975.
DOI : 10.1056/NEJM197512112932404

H. Moutsopoulos, A. Steinberg, A. Fauci, H. Lane, and N. Papadopoulos, High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome, J Immunol, vol.130, pp.2663-2668, 1983.

M. Pertovaara and M. Korpela, Serum ??2 microglobulin correlates with the new ESSDAI in patients with Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.70, issue.12, pp.2236-2237, 2011.
DOI : 10.1136/ard.2011.153098

L. Quartuccio, S. Salvin, M. Fabris, M. Maset, and E. Pontarini, BLyS upregulation in Sjögren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands, 2012.

R. Seror, P. Ravaud, X. Mariette, H. Bootsma, and E. Theander, EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.968-72, 2011.
DOI : 10.1136/ard.2010.143743

D. Smith, J. Neal, and S. Holmberg, Unexplained Opportunistic Infections and CD4+ T-Lymphocytopenia without HIV Infection -- An Investigation of Cases in the United States, New England Journal of Medicine, vol.328, issue.6, pp.373-379, 1993.
DOI : 10.1056/NEJM199302113280601

G. Cambridge, W. Stohl, M. Leandro, T. Migone, and D. Hilbert, Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse, Arthritis & Rheumatism, vol.174, issue.3, pp.723-755, 2006.
DOI : 10.1002/art.21650

F. Lavie, C. Miceli-richard, M. Ittah, J. Sellam, and J. Gottenberg, Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production, Annals of the Rheumatic Diseases, vol.66, issue.5, pp.700-703, 2007.
DOI : 10.1136/ard.2006.060772

M. Voulgarelis and H. Moutsopoulos, Mucosa-Associated Lymphoid Tissue Lymphoma in Sj??gren's Syndrome: Risks, Management, and Prognosis, Rheumatic Disease Clinics of North America, vol.34, issue.4, pp.921-954, 2008.
DOI : 10.1016/j.rdc.2008.08.006

A. Tzioufas, D. Boumba, F. Skopouli, and H. Moutsopoulos, Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sj??gren's syndrome, Arthritis & Rheumatism, vol.36, issue.5, pp.767-72, 1996.
DOI : 10.1002/art.1780390508

J. Gottenberg and M. X. , Primary Sjogren???s Syndrome: Time for Prospective Cohorts, Current Pharmaceutical Biotechnology, vol.13, issue.10, pp.2022-2027, 2012.
DOI : 10.2174/138920112802273128

J. Gottenberg, M. Busson, P. Loiseau, J. Cohen-solal, and V. Lepage, In primary Sj??gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response, Arthritis & Rheumatism, vol.20, issue.8, pp.2240-2245, 2003.
DOI : 10.1002/art.11103

S. Candon, J. Gottenberg, D. Bengoufa, L. Chatenoud, and M. X. , Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1208-1220, 2009.
DOI : 10.1136/ard.2008.095257

J. Gottenberg, J. Sellam, M. Ittah, F. Lavie, and A. Proust, No evidence for an association between the 2871 T/C promoter polymorphism in the B-cellactivating factor gene and primary Sjögren's syndrome, Arthritis Research & Therapy, vol.8, issue.1, p.30, 2006.
DOI : 10.1186/ar1884

J. Nossent, S. Lester, D. Zahra, C. Mackay, and M. Rischmueller, Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome, Rheumatology, vol.47, issue.9, pp.1311-1316, 2008.
DOI : 10.1093/rheumatology/ken246

L. Gragnani, A. Piluso, C. Giannini, P. Caini, and E. Fognani, Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: Role of polymorphic variants of BAFF promoter and Fc?? receptors, Arthritis & Rheumatism, vol.1107, issue.5, pp.1446-51, 2011.
DOI : 10.1002/art.30274

A. Novak, S. Slager, Z. Fredericksen, A. Wang, and M. Manske, Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma, Cancer Research, vol.69, issue.10, pp.4217-4241, 2009.
DOI : 10.1158/0008-5472.CAN-08-4915

A. Novak, D. Grote, S. Ziesmer, M. Kline, and M. Manske, Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders, Journal of Clinical Oncology, vol.24, issue.6, pp.983-990, 2006.
DOI : 10.1200/JCO.2005.02.7938

F. Emmerich, G. Bal, A. Barakat, J. Milz, and C. Mühle, High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura, British Journal of Haematology, vol.166, issue.2, pp.309-310, 2007.
DOI : 10.1126/science.1061965